Development
- Design biopharmaceutical development plans that span preclinical, clinical, regulatory, immunogenicity risk assessment, etc.
- Team with subject matter experts in the design of a biopharmaceutical development plan
- Review current program to insure that FDA requirements are met
- Conduct risk analysis


HartmannWillner LLC | 1000 6th Street SW, #215 | Washington, D.C. 20024 | United States